Skip to main content

Table 1 Source breakdown of Acinetobacter baumannii complex from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) by year

From: Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program

Strata

TSAR III (2002)

TSAR IV (2004)

TSAR V (2006)

TSAR VI (2008)

TSAR VII (2010)

TSAR III-VII Combined

P a

N

%

N

%

N

%

N

%

N

%

N

%

Hospital type

 Medical centers (11)

162

54.4

124

47.9

126

41.4

172

41.1

151

41.8

735

44.8

0.002

 Regional hospitals (15)

136

45.6

135

52.1

178

58.6

246

58.9

210

58.2

905

55.2

0.002

Region

 North (7)

90

30.2

70

27.0

76

25.0

118

28.2

118

32.7

472

28.8

0.2354

 Central (8)

94

31.5

91

35.1

109

35.9

189

45.2

144

39.9

627

38.2

0.0024

 South (8)

77

25.8

57

22.0

76

25.0

65

15.6

68

18.8

343

20.9

0.0032

 East (3)

37

12.4

41

15.8

43

14.1

46

11.0

31

8.6

198

12.1

0.0194

Patient location

 ICU

100

33.6

105

40.5

103

33.9

157

37.6

135

37.4

600

36.6

0.3848

 Non-ICU

174

58.4

138

53.3

165

54.3

227

54.3

201

55.7

905

55.2

0.7578

 OPD/ER

24

8.1

16

6.2

36

11.8

34

8.1

25

6.9

135

8.2

0.1104

Specimen type

 Respiratory

157

52.7

136

52.5

137

45.1

208

49.8

184

51.0

822

50.1

0.3294

 Blood

33

11.1

28

10.8

34

11.2

84

20.1

65

18.0

244

14.9

0.0002

 Pus/discharge

49

16.4

40

15.4

56

18.4

40

9.6

34

9.4

219

13.4

0.0005

 Urine

34

11.4

30

11.6

50

16.4

57

13.6

45

12.5

216

13.2

0.332

 Others

25

8.4

25

9.7

27

8.9

29

6.9

33

9.1

139

8.5

0.7321

Total

298

259

304

418

361

1640

 
  1. aThe differences of hospital types, regions, patient locations, and specimen types among TSAR III to VII were compared using Pearson's chi-squared test.